MFDS — authorised 4 April 2003
- Marketing authorisation holder: LG LIFE SCIENCES
- Status: likely_approved
🇰🇷 Factive in South Korea
MFDS authorised Factive on 4 April 2003
Marketing authorisation
Factive in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Factive approved in South Korea?
Yes. MFDS authorised it on 4 April 2003.
Who is the marketing authorisation holder for Factive in South Korea?
LG LIFE SCIENCES holds the South Korean marketing authorisation.